Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 114 for chemotherapy-induced anemia
NCT00119600Phase 2Terminated
- Sponsor
- Amgen
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of AMG 114 in Chemotherapy-induced anemia (CIA), sponsored by Amgen. Status: terminated.
02
Drugs
AMG 114
03
Conditions
Chemotherapy-induced anemia (CIA)
Beyond the preview
Go deeper on NCT00119600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119600.